Cell-Based Composite Materials with Programmed Structures and Functions

US2016208238A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016208238-A1
Application numberUS-201614996048-A
CountryUS
Kind codeA1
Filing dateJan 14, 2016
Priority dateApr 25, 2012
Publication dateJul 21, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to the use of silicic acid to transform biological materials, including cellular architecture into inorganic materials to provide biocomposites (nanomaterials) with stabilized structure and function. In the present invention, there has been discovered a means to stabilize the structure and function of biological materials, including cells, biomolecules, peptides, proteins (especially including enzymes), lipids, lipid vesicles, polysaccharides, cytoskeletal filaments, tissue and organs with silicic acid such that these materials may be used as biocomposites. In many instances, these materials retain their original biological activity and may be used in harsh conditions which would otherwise destroy the integrity of the biological material. In certain instances, these biomaterials may be storage stable for long periods of time and reconstituted after storage to return the biological material back to its original form. In addition, by exposing an entire cell to form CSCs, the CSCs may function to provide a unique system to study enzymes or a cascade of enzymes which are otherwise unavailable.

First claim

Opening claim text (preview).

We claim: 1 . A method to synthesize cell/silica composites (CSCs), comprising incubating a plurality of cells in a silicic acid solution to provide cell/silica composite particles. 2 . The method of claim 1 , wherein the plurality of cells comprises mammalian cells, prokaryotic cells, plant cells, cultured cells, tissue, or biological organism. 3 . The method of claim 1 , wherein the plurality of cells is genetically, chemically, or physically modified. 4 . The method of claim 1 , further comprising fixing the plurality of cells in a fixative prior to the incubating step. 5 . The method of claim 1 , wherein the silicic acid solution is osmotically balanced. 6 . The method of claim 1 , further comprising plating the plurality of cells on a substrate prior to the incubating step. 7 . The method of claim 1 , further comprising patterning the plurality of cells on a surface prior to the incubating step. 8 . The method of claim 1 , wherein the plurality of cells are suspended in the silicic acid solution. 9 . The method of claim 8 , further comprising dehydrating the cell/silica composite particles to provide monodisperse cell/silica composite particles. 10 . The method of claim 1 , wherein the silicic acid solution comprises tetramethoxysilane, tetraethoxysilane, or a mixture thereof. 11 . The method of claim 1 , further comprising calcinating the cell/silica composite particles at an elevated temperature to provide silica replicas. 12 . The method of claim 11 , wherein the elevated temperature is greater than 500° C. 13 . The method of claim 11 further comprising reconstituting a cellular function on the silica replicas. 14 . The method of claim 1 , further comprising pyrolyzing the cell-silica composite particles at a high temperature in an inert atmosphere to provide carbonized-cell/silica composite particles. 15 . A population of CSCs which are produced by a method according to claim 1 . 16 . The population of CSCs according to claim 15 which is storage stable. 17 . A cell/silica composite (CSC) comprising a transformed cell, which further comprises a silicon dioxide coating onto a structure which is found in said cell. 18 . The CSC of claim 17 , wherein the coating is a conformal coating. 19 . The CSC of claim 17 , further comprising a preserved shape and/or feature, as compared to the original cell. 20 . The CSC of claim 17 , wherein the CSC is dehydrated and/or calcined.

Assignees

Inventors

Classifications

  • G01N1/2806Primary

    Means for preparing replicas of specimens, e.g. for microscopal analysis · CPC title

  • Silica · CPC title

  • Shadowing samples · CPC title

  • C12N11/14Primary

    Enzymes or microbial cells immobilised on or in an inorganic carrier · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016208238A1 cover?
The present invention is directed to the use of silicic acid to transform biological materials, including cellular architecture into inorganic materials to provide biocomposites (nanomaterials) with stabilized structure and function. In the present invention, there has been discovered a means to stabilize the structure and function of biological materials, including cells, biomolecules, peptide…
Who is the assignee on this patent?
Sandia Corp, Stc Unm
What technology area does this patent fall under?
Primary CPC classification G01N1/2806. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Jul 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).